HomeCompareOPHLF vs PG

OPHLF vs PG: Dividend Comparison 2026

OPHLF yields 3.22% · PG yields 2.93%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OPHLF wins by $9.75M in total portfolio value
10 years
OPHLF
OPHLF
● Live price
3.22%
Share price
$14.55
Annual div
$0.47
5Y div CAGR
76.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.80M
Annual income
$8,123,319.23
Full OPHLF calculator →
PG
Procter & Gamble
● Live price
2.93%
Share price
$144.42
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.5K
Annual income
$9,992.83
Full PG calculator →

Portfolio growth — OPHLF vs PG

📍 OPHLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPHLFPG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPHLF + PG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPHLF pays
PG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPHLF
Annual income on $10K today (after 15% tax)
$273.36/yr
After 10yr DRIP, annual income (after tax)
$6,904,821.35/yr
PG
Annual income on $10K today (after 15% tax)
$248.80/yr
After 10yr DRIP, annual income (after tax)
$8,493.91/yr
At 15% tax rate, OPHLF beats the other by $6,896,327.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPHLF + PG for your $10,000?

OPHLF: 50%PG: 50%
100% PG50/50100% OPHLF
Portfolio after 10yr
$4.92M
Annual income
$4,066,656.02/yr
Blended yield
82.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PG right now

OPHLF
No analyst data
Altman Z
4.8
Piotroski
8/9
PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+16.1% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPHLF buys
0
PG buys
0
No recent congressional trades found for OPHLF or PG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPHLFPG
Forward yield3.22%2.93%
Annual dividend / share$0.47$4.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR76.7%31.1%
Portfolio after 10y$9.80M$51.5K
Annual income after 10y$8,123,319.23$9,992.83
Total dividends collected$9.63M$29.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OPHLF vs PG ($10,000, DRIP)

YearOPHLF PortfolioOPHLF Income/yrPG PortfolioPG Income/yrGap
1← crossover$11,268$568.26$11,004$383.73+$264.00OPHLF
2$13,114$1,057.44$12,207$521.25+$907.00OPHLF
3$16,065$2,032.36$13,678$713.84+$2.4KOPHLF
4$21,301$4,111.31$15,513$987.38+$5.8KOPHLF
5$31,794$9,002.23$17,858$1,382.44+$13.9KOPHLF
6$56,209$22,189.83$20,929$1,964.45+$35.3KOPHLF
7$124,928$64,784.43$25,069$2,842.17+$99.9KOPHLF
8$371,454$237,780.36$30,826$4,202.54+$340.6KOPHLF
9$1,564,997$1,167,541.06$39,116$6,379.22+$1.53MOPHLF
10$9,797,866$8,123,319.23$51,534$9,992.83+$9.75MOPHLF

OPHLF vs PG: Complete Analysis 2026

OPHLFStock

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONGENTYS tablets for the treatment of Parkinson's disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis. In addition, it is developing products for esophageal, urothelial carcinoma, Hodgkin's lymphoma, ovarian, bladder, prostate, hepatocellular carcinoma, pancreatic, biliary tract, virus positive/negative solid carcinoma, gastric, esophageal, urothelial, hepatocellular, thyroid, colorectal, melanoma, acute myeloid leukemia, non-small cell lung cancer, primary central nervous system lymphoma, myelodysplastic syndrome, polymyositis/dermatomyositis, tachyarrhythmia, pemphigus, generalized scleroderma, enthesopathy, diabetic polyneuropathy, neurodegenerative, autoimmune, narcolepsy, and thrombosis. The company was founded in 1717 and is headquartered in Osaka, Japan.

Full OPHLF Calculator →

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →
📬

Get this OPHLF vs PG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPHLF vs SCHDOPHLF vs JEPIOPHLF vs OOPHLF vs KOOPHLF vs MAINOPHLF vs KMBOPHLF vs CLOPHLF vs CHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.